Washington DC (PRWEB) April 18, 2012
The World Molecular Imaging Society and Cambridge Healthtech Institute have partnered on a short course taking plan June 6, 2012 in Philadelphia, PA that will also be streamed over the internet to cater to the international marketplace.
The short course – Molecular Imaging in Drug Discovery & Development: Back to Basics – will feature presentations from industry experts and leading academicians brought together to discuss how choosing the right imaging technology, understanding the strengths and limitations of available modalities and their ideal combination with imaging tools is therefore of utmost importance.
Presentations will be given by Simon Williams, Ph.D., Senior Scientist, Biomedical Imaging, Genentech, Thomas Bocan, Ph.D., Senior Director, Pre-Clinical Imaging, Pharmatherapeutics Precision Medicine, Worldwide Research & Development, Pfizer, Inc., Erik M. Shapiro, Ph.D., Assistant Professor of Diagnostic Radiology and Biomedical Engineering, Yale University School of Medicine, and James Gee, PhD, Professor and Director, Penn Image and Computing Science Laboratory, University of Pennsylvania.
“We are excited by the opportunity to provide the imaging community with a comprehensive overview of preclinical molecular imaging, its challenges and applications. This training course, designed in collaboration with World Molecular Imaging Congress (WMIC), will feature an array of important topics such as strength and limitations of various imaging modalities in drug discovery and development, preclinical PET and MRI, and quantitative image analysis. The collaboration is intended to bring together imaging specialists working in academic and industry settings. The geographically broad community of WMIC is offered with an option to join the course remotely via webcast,” said Conference Producer Marina Filshtinsky, M.D.
This short course is to be held in conjunction with the 11th Annual World Pharmaceutical Congress, taking place June 5-7, 2012 in Philadelphia. World Pharma Congress covers topics around drug discovery for various therapeutic areas (Parkinson's Disease, Alzheimer's Disease, Pain), technologies related to discovery and development (Preclinical Models in Oncology and Molecular Imaging) and topics related to drug safety (Cardiotoxicity and Hepatotoxicity). The conferences all offer informative and pragmatic viewpoints for tackling issues relevant to chemists, biologists, pharmacologists, toxicologists and clinicians alike. Each conference features presentations, interactive panels and technology talks that cover the very latest on the topic, both on the scientific and the technical side.
Additional information can be found at http://www.WorldPharmaCongress.com
WMIS is the world's most innovative and leading society in molecular imaging and molecular medicine. With the rise of the molecular imaging industry and the associated research, WMIS is the only organization that is connecting all the dots in the industry and is working to bring all stakeholders together by Smashing the Silos and Leading Innovation Convergence in molecular medicine; both for practitioners and researchers, who are defining the future of molecular imaging, WMIS enhances the potential and applications of innovation.
WMIC is the world's most innovative, science and technology led, event. It brings the world's top molecular imaging scientists, technology experts, researchers, and business leaders together to define the future of the molecular imaging field. As the most exciting event in the field, it attracts participation from across the entire value chain of molecular imaging.